October 11, 2017
Fumi Yamamoto, Director, Evaluation and Licensing Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW The Ministry of Health, Labor and Welfare (MHLW) plans to present a basic guide on post-marketing surveillance (PMS) to be conducted for ethical drugs subject to...read more